HCPCS drug code · CMS crosswalk
Nufymco HCPCS Code
In short
Nufymco is billed under HCPCS Q5168 — Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg. One billing unit is 0.1 mg. CMS's crosswalk lists 1 Nufymco NDC under this code.
Reference
- Q5168
- Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mgBilling unit: 0.1 mg
- Labelers
- Zydus Pharmaceuticals (USA) Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Added October 2026. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Nufymco units and claim line
Enter the dose given to get the Q5168 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Nufymco NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 70710-2173-01 | Q5168 | Zydus Pharmaceuticals (USA) Inc. | 0.05 | 5 |
Nufymco: common questions
- What is the HCPCS code for Nufymco?
- Nufymco is billed under HCPCS Q5168 — Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg. One billing unit is 0.1 mg. CMS's crosswalk lists 1 Nufymco NDC under this code.
- How many Q5168 billing units are in a package of Nufymco?
- CMS lists 5 billing units per package, depending on the NDC, where one unit is 0.1 mg. Units to report are based on the dose given, not the package.
- Is Q5168 a CPT code?
- No. Q5168 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.